Webinar: From Submission to Innovation
The publication of the eCTD Module 1 Specifications and Validation Criteria represents a major milestone for the Egyptian Drug Authority (EDA) on its path to digital transformation. To mark this occasion, our valued partner in Egypt, DAF- Digital Access to Finance, with whom we have the honor of accompanying the EDA, has organized an exceptional webinar series that thoroughly examines this latest development.
In three webinars, experienced professionals will discuss the various aspects of the latest updates. They will cover Egypt’s new digital regulatory requirements, the eCTD process, as well as submissions, validation, document management, and innovative pharmacometrics.
In the third session, we explore how innovative digital solutions can streamline the entire eCTD lifecycle, from the initial submission to updates across different regions. You will gain practical insights into submission quality, DAF services, and the future of drug development through advanced approaches. Join us to discover how technology and pharmacometrics can make regulatory processes more efficient, connected, and future-ready.
Date: 15 October 2026
Time: 12:00 PM to 2:00 PM Cairo Time (GMT+3) ι 11:00 AM to 01:00 PM CEST
Registration: https://events.teams.microsoft.com/event/82d22c93-81f1-4e40-8cdd-061f29298990@9b0bcdeb-6e81-4474-b1f9-fa227c7b140a?source=copyLinkOneEventsShareDialog
Participation is free of charge.
Please note that a big part of the webinar will be in Arabic.
Topics include:
• EXTEDOpulse: A Comprehensive Regulatory Information Management Software Solution
• End-to-End eCTD regulatory process management demo in different cases, e.g. lifecycle & regions
• Submission Quality Best Practices
• DAF Pharmacometrics Excellence Center (DPEC): Model-Informed Drug Development, PBPK, Population PK & Regulatory Modeling
If you would like to learn more about how DAF and EXTEDO contribute to bringing the EDA's vision to life, have a look at our blog post: Egyptian Drug Authority and EXTEDO Launch Phase II of Egypt’s Pharmaceutical Digital Transformation | EXTEDO
Your Speakers:
